Ignite Creation Date:
2025-12-24 @ 1:59 PM
Ignite Modification Date:
2026-02-20 @ 1:39 PM
Study NCT ID:
NCT02585895
Status:
COMPLETED
Last Update Posted:
2022-11-30
First Post:
2015-10-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-21
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-20
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-07
First Submit QC Date:
None
Study First Post Date:
2015-10-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-21
Results First Submit QC Date:
None
Results First Post Date:
2017-09-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-04
Last Update Post Date:
2022-11-30
Last Update Post Date Type:
ACTUAL